Citations

Clear

2429 citation(s) found for "Shah, P".

Nitric oxide synthase generates nitric oxide locally to regulate compartmentalized protein S-nitrosylation and protein trafficking
Iwakiri, Yasuko , Satoh, Ayano , Chatterjee, Suvro , Toomre, Derek , Chalouni, Cécile , Fulton, David , Groszmann, Roberto J., Shah, Vijay H. , Sessa, William C.

Mayo Clinic

Proceedings of the National Academy of Sciences | December 14, 2006 | Volume: 103 | Issue: 52 | Pages: 19777-19782

10.1073/pnas.0605907103 | PMID 17170139 Get It

Nitric oxide (NO) is a highly diffusible and short-lived physiological messenger. Despite its diffusible nature, NO modifies thiol groups of specific cysteine residues in target proteins and alters protein function via S-nitrosylation. Although intracellular S-nitrosylation is a specific posttranslational modification, the defined localization of an NO source (nitric oxide synthase, NOS) with protein S-nitrosylation has never been directly demonstrated. Endothelial NOS (eNOS) is localized mainly on the Golgi apparatus and in plasma membrane caveolae. Here, we show by using eNOS targeted to either the Golgi or the nucleus that S-nitrosylation is concentrated at the primary site of eNOS localization. Furthermore, localization of eNOS on the Golgi enhances overall Golgi protein S-nitrosylation, the specific S-nitrosylation of N -ethylmaleimide-sensitive factor and reduces the speed of protein transport from the endoplasmic reticulum to the plasma membrane in a reversible manner. These data indicate that local NOS action generates organelle-specific protein S-nitrosylation reactions that can regulate intracellular transport processes.
Ketoacidosis during a Low-Carbohydrate Diet
Shah, Pankaj, Isley, William L.

Mayo Clinic

New England Journal of Medicine | January 4, 2006 | Volume: 354 | Issue: 1 | Pages: 97-98

10.1056/nejmc052709 | PMID 16394313 Get It

Projecting future drug expenditures—2006
Hoffman, James M. , Shah, Nilay D. , Vermeulen, Lee C. , Schumock, Glen T., Grim, Penny, Hunkler, Robert J., Hontz, Karrie M.

Mayo Clinic

American Journal of Health-System Pharmacy | January 3, 2006 | Volume: 63 | Issue: 2 | Pages: 123-138

10.2146/ajhp050446 | PMID 16390926 Get It

Regulatory role of dynamin‐2 in VEGFR‐2/KDR‐mediated endothelial signaling
Kang‐Decker, Ningling, Hughes, Deborah A., Shah, Vijay H. , McNiven, Mark A. , Bhattacharya, Resham , Mukherjee, Priyabrata , Mukhopadhyay, Debabrata

Mayo Clinic

The FASEB Journal | July 27, 2005 | Volume: 19 | Issue: 12 | Pages: 1692-1694

10.1096/fj.05-3889fje | PMID 16049137 Get It

ABSTRACT Vascular endothelial growth factor receptor‐2 (VEGFR‐2, also known as KDR) is a receptor tyrosine kinase (RTK) regulating mitogenic, chemotactic, permeability, and survival signals in vascular endothelial cells (EC) in response to its ligand, vascular permeability factor/VEGF (VPF/VEGF), arguably the most important angiogenic cytokine. However, the compartmentalization of KDR in EC and the mechanisms regulating this process have not been well defined. Here, we demonstrate that KDR is present on the plasma membrane, on endosomes, and in the perinuclear region of EC and colocalizes with early endosomal antigen (EEA1), caveolin‐1, and dynamin‐2, a signal transducing GTPase involved in receptor endocytosis. Furthermore, we also observed that dynamin‐2 coimmunoprecipitates with KDR and is required for EC signaling/survival. Interestingly, EC overexpressing a mutant form of dynamin deficient in GTP binding (K44A) caused a selective inhibition in KDR protein level and endosomal vesicle formation and induced cell cycle arrest by inducing p21. Taken together, our findings suggest that dynamin‐2 regulates KDR expression and function and hence plays an important role in VPF/VEGF mediated angiogenesis.
Functional Interdependence and Colocalization of Endothelial Nitric Oxide Synthase and Heat Shock Protein 90 in Cerebral Arteries
Khurana, Vini G., Feterik, Kristian, Springett, Margaret J., Eguchi, Daihiko , Shah, Vijay H. , Katušić, Zvonimir S.

Mayo Clinic

Journal of Cerebral Blood Flow & Metabolism | November 18, 2003 | Volume: 20 | Issue: 11 | Pages: 1563-1570

10.1097/00004647-200011000-00006 | PMID 11083231 Get It

Heat shock protein 90 (HSP90), an essential component of several signal transduction systems, participates in the activation of endothelial nitric oxide synthase (eNOS) in cells. The objective of the current study was to determine if HSP90 and eNOS were functionally interdependent and colocalized in the cerebral circulation. The authors used isometric force recording, cyclic 3′5′-guanosine monophosphate (cGMP) radioimmunoassay (RIA), and immunogold electron microscopy (EM) to study canine basilar artery. They found that geldanamycin (0.1 to 10 μg/mL), a selective HSP90 inhibitor, caused concentration-dependent contractions in arterial rings (n = 6 dogs). Contractions to geldanamycin were unaffected by a cyclooxygenase inhibitor, indomethacin (10 μmol/L; P < 0.05, n = 6). Functional evidence for interaction between HSP90 and nitric oxide (NO)-mediated signaling included observations that the contractile effect of geldanamycin was the following: (1) endothelium-dependent, (2) abolished by N g -nitro-l-arginine methylester (L-NAME; 0.3 mmol/L), and (3) nonadditive with the contractile effect of this NOS inhibitor ( P < 0.01, n = 6 for each). Furthermore, RIA showed significant reduction in cGMP levels in arteries treated with geldanamycin (3 μg/mL; P < 0.02, n = 8), whereas immunogold EM demonstrated areas of colocalization of HSP90 and eNOS selectively in the cytoplasm of endothelial cells. The current findings suggest that in cerebral arteries, endothelial HSP90 plays an important role in modulation of basal NO-mediated signaling. This interaction may be particularly important in stress-induced up-regulation of HSP90 with subsequent alteration of vasomotor function.
Diverse Origin and Function of Cells With Endothelial Phenotype Obtained From Adult Human Blood
Gulati, Rajiv , Jevremović, Dragan , Peterson, Timothy E., Chatterjee, Suvro , Shah, Vijay H. , Vile, Richard G. , Simari, Robert D., Jevremovic, Dragan

Mayo Clinic

Circulation Research | November 11, 2003 | Volume: 93 | Issue: 11 | Pages: 1023-1025

10.1161/01.res.0000105569.77539.21 | PMID 14605020 Get It

Cells with endothelial phenotype generated from adult peripheral blood have emerging diagnostic and therapeutic potential. This study examined the lineage relationship between, and angiogenic function of, early endothelial progenitor cells (EPCs) and late outgrowth endothelial cells (OECs) in culture. Culture conditions were established to support the generation of both EPCs and OECs from the same starting population of peripheral blood mononuclear cells (PBMCs). Utilizing differences in expression of the surface endotoxin receptor CD14, it was determined that the vast majority of EPCs arose from a CD14 + subpopulation of PBMCs but OECs developed exclusively from the CD14 − fraction. Human OECs, but not EPCs, expressed key regulatory proteins endothelial nitric oxide synthase (eNOS) and caveolin-1. Moreover, OECs exhibited a markedly greater capacity for capillary morphogenesis in in vitro and in vivo matrigel models, tube formation by OECs being in part dependent on eNOS function. Collectively, these data indicate lineage and functional heterogeneity in the population of circulating cells capable of assuming an endothelial phenotype and provide rationale for the investigation of new cell-therapeutic approaches to ischemic cardiovascular disease.
Calcification in atherosclerosis: Bone biology and chronic inflammation at the arterial crossroads
Doherty, Terence M. , Asotra, Kamlesh, Fitzpatrick, Lorraine A. , Qiao, Jian-Hua, Wilkin, Douglas J., Detrano, Robert, Dunstan, Colin R. , Shah, Prediman K. , Rajavashisth, Tripathi B.

Mayo Clinic

Proceedings of the National Academy of Sciences | October 1, 2003 | Volume: 100 | Issue: 20 | Pages: 11201-11206

10.1073/pnas.1932554100 | PMID 14500910 Get It

Dystrophic or ectopic mineral deposition occurs in many pathologic conditions, including atherosclerosis. Calcium mineral deposits that frequently accompany atherosclerosis are readily quantifiable radiographically, serve as a surrogate marker for the disease, and predict a higher risk of myocardial infarction and death. Accelerating research interest has been propelled by a clear need to understand how plaque structure, composition, and stability lead to devastating cardiovascular events. In atherosclerotic plaque, accumulating evidence is consistent with the notion that calcification involves the participation of arterial osteoblasts and osteoclasts. Here we summarize current models of intimal arterial plaque calcification and highlight intriguing questions that require further investigation. Because atherosclerosis is a chronic vascular inflammation, we propose that arterial plaque calcification is best conceptualized as a convergence of bone biology with vascular inflammatory pathobiology.
Inhibition of GTP-dependent vesicle trafficking impairs internalization of plasmalemmal eNOS and cellular nitric oxide production
Chatterjee, Suvro , Cao, Sheng , Peterson, Timothy E., Simari, Robert D., Shah, Vijay H.

Mayo Clinic

Journal of Cell Science | July 29, 2003 | Volume: 116 | Issue: 17 | Pages: 3645-3655

10.1242/jcs.00664 | PMID 12876216 Get It

The Ca2+ mobilizing peptide, bradykinin (BK), stimulates endothelial nitric oxide synthase (eNOS)-derived cellular nitric oxide (NO)production in association with altering the subcellular distribution of the enzyme. In the present study we examine the influence of cellular GTPases,particularly the large GTPase dynamin, on BK-mediated eNOS localization and cellular NO production. BK stimulation of ECV cells, which were stably transfected with eNOS-GFP (eNOS-GFP ECV304), increased NO production. This was associated with the mobilization of eNOS-GFP protein into Triton X-100-insoluble fractions of cell lysates, and an internalization of plasmalemmal eNOS-GFP in live and fixed ECV 304 cells. Incubation of digitonin-permeabilized ECV304 cells with the non-hydrolyzed GTP analog,GTP-γ-S, abrogated the BK-mediated internalization of eNOS-GFP as assessed by confocal microscopy. Conversely, inhibition of clathrin-dependent endocytosis, via overexpression of AP 180 or pretreatment of cells with chlorpromazine, did not influence BK-mediated eNOS redistribution. Furthermore, specific inhibition of dynamin-2 GTPase function by overexpression of a dominant negative construct, K44A, prevented the BK-mediated enrichment of eNOS-GFP within low buoyant density,caveolin-enriched fractions of eNOS-GFP ECV304 cell lysates. Dynamin-2 K44A overexpression also markedly impaired BK-dependent, L-NAME-inhibited NO production as did incubation of permeabilized cells with GTP-γ-s. These studies demonstrate that disruption of dynamin- and GTP-dependent, but clathrin-independent, vesicle trafficking pathways impairs BK-dependent cellular NO production, via inhibition of the internalization of eNOS-containing plasmalemmal vesicles.
Human Granulocyte Colony-Stimulating Factor in Children With High-Risk Acute Lymphoblastic Leukemia: A Children’s Cancer Group Study
Heath, John A. , Steinherz, Peter G. , Altman, Arnold J., Sather, Harland N., Jhanwar, Suresh C., Halpern, Steven, Pieters, Richard S., Shah, Narayan R., Steinherz, Laurel J., Tannous, Raymond, Terry, William W. , Trigg, Michael E.

Mayo Clinic

Journal of Clinical Oncology | April 15, 2003 | Volume: 21 | Issue: 8 | Pages: 1612-1617

10.1200/jco.2003.07.129 | PMID 12697887 Get It

Purpose: To investigate the effect of granulocyte colony-stimulating factor (G-CSF) on hematopoietic toxicities, supportive care requirements, time to complete intensive therapy, and event-free survival (EFS) and overall survival (OS) in children with high-risk acute lymphoblastic leukemia (HR-ALL). Patients and Methods: A total of 287 children with HR-ALL were randomly assigned to intensive chemotherapy regimens (New York I [NY I] or NY II) as part of the Children’s Cancer Group (CCG)-1901 protocol. The induction phases consisted of five drugs (vincristine, prednisone, l-asparaginase, daunorubicin, and cyclophosphamide). Initial consolidation comprised six-agent chemotherapy combined with 18 Gy of total-brain irradiation. Patients were randomly assigned to receive G-CSF (5 μg/kg/day) during either induction or initial consolidation. A crossover study analysis was done on the 259 patients who completed both phases of therapy. Results: The mean time to neutrophil recovery (≥ 0.5 × 109/L) was reduced with G-CSF (16.7 v 19.1 days, P = .0003); however, patients who received G-CSF did not have significantly reduced episodes of febrile neutropenia (149 v 164, P = .41), positive blood cultures (57 v 61, P = .66), or serious infections (75 v 79, P = .62). Hospitalization (14.0 v 13.9 days, P = .87) and induction therapy completion times (NY I, 30.3 v 31.3 days, P = .11; NY II, 33.4 v 32.3 days, P = .40) were not significantly altered. There were no differences in 6-year EFS (P = .24) or OS (P = .54) between patients receiving or not receiving G-CSF on CCG-1901, NY I and NY II. Conclusion: Children with high-risk ALL do not appear to benefit from prophylactic G-CSF.